Chromosomal aneuploidy in 25 mammographically detected breast lesions
(MDBL) were determined on cytological smears using directly labeled pe
ricentromeric probes for chromosomes 7 to 12, 17, 18, and X. The lesio
ns included seven nonproliferative (NP) lesions, seven atypical hyperp
lasias (AHs), and 11 carcinomas (CAs). No other significant histologic
al findings were identified in the remaining specimens except in two m
ammographically detected NP lesions, where foci of AH were present in
adjacent sections; therefore, these two specimens were included in the
AH lesion group (moderately increased risk lesions). Corresponding ti
ssue sections were evaluated, and the results were correlated with flu
orescent in situ hybridization (FISH) results. Monosomy was defined as
the loss of one signal in greater than or equal to 15% of cells, and
trisomy or tetrasomy was defined by the presence of three or more sign
als in greater than or equal to 3% of cells. Chromosomal aberrations w
ere detected in 2 of 5 NP, 9 of 9 AH, and 11 of 11 CA groups. The mean
number of cells with three or more signals, for all chromosomes, was
1.04 +/- 0.9 in the NP group, 8.5 +/- 9.4 in the AH group, and 20.2 +/
- 5.4 in the CAs. A significant statistical difference was noted betwe
en the different groups (P = .0001). Chromosomal gain was the most com
mon aberration and involved all chromosomes. The X chromosome was the
only individual chromosome with significant differences in NP, AH, and
CA groups. Chromosomal loss was observed in five specimens (20%) and
involved chromosomes 8, 10, 17, and 18. The authors conclude (1) signi
ficant chromosomal aberrations can be detected in AH lesions and in NP
epithelium from patients with moderately increased risk lesions; (2)
numerical chromosomal aberrations tend to increase with progression of
disease; (3) the frequent chromosomal gains/losses involving AH sugge
st that some AH may display submicroscopic features of malignancy; and
(4) combined chromosomal aberrations allow for significant categoriza
tion of breast lesions, especially in cytology specimens. (C) 1996 by
W.B. Saunders Company